Risk of radionecrosis in brain metastases treated with SRT and systemic therapy

被引：0
|
作者：
Holub, K. [1 ,2 ,3 ]
Louvel, G. [2 ]
机构：
[1] Univ Barcelona, Hosp Clin Barcelona, Radiat Oncol, Barcelona, Spain
[2] Gustave Roussy, Radiat Oncol, Villejuif, France
[3] SEOR CRIS Fdn, Bengaluru, India
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-0884
引用
收藏
页码：S474 / S475
页数：2
相关论文
共 50 条
  • [41] Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases
    Zachary A. Kohutek
    Yoshiya Yamada
    Timothy A. Chan
    Cameron W. Brennan
    Viviane Tabar
    Philip H. Gutin
    T. Jonathan Yang
    Marc K. Rosenblum
    Åse Ballangrud
    Robert J. Young
    Zhigang Zhang
    Kathryn Beal
    Journal of Neuro-Oncology, 2015, 125 : 149 - 156
  • [42] Risk of radionecrosis after hypofractionated stereotactic radiotherapy targeting the postoperative resection cavity of brain metastases
    Keller, A.
    Dore, M.
    Antoni, D.
    Menoux, I.
    Thillays, F.
    Clavier, J. B.
    Delpon, G.
    Jarnet, D.
    Bourrier, C.
    Lefebvre, F.
    Chibbaro, S.
    Darie, I.
    Proust, F.
    Noel, G.
    CANCER RADIOTHERAPIE, 2017, 21 (05): : 377 - 388
  • [43] Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases
    Tonse, Raees
    Tom, Martin C.
    Mehta, Minesh P.
    Ahluwalia, Manmeet S.
    Kotecha, Rupesh
    CANCERS, 2021, 13 (15)
  • [44] Systemic therapy for brain metastases from breast cancer
    Lin, Nancy U.
    CANCER INVESTIGATION, 2007, 25 : 5 - 5
  • [45] RESECTION CAVITY FAILURE OF MELANOMA BRAIN METASTASES WHEN TREATED WITH SYSTEMIC THERAPY, WITH OR WITHOUT FOCAL RADIOTHERAPY
    Susko, Matthew S.
    Vasudevan, Harish N.
    Ma, Lijun
    Nakamura, Jean
    Raleigh, David
    Boreta, Lauren
    Fogh, Shannon
    Theodosopoulos, Philip
    McDermott, Michael
    Tsai, Katy
    Sneed, Penny
    Braunstein, Steve
    NEURO-ONCOLOGY, 2020, 22 : 182 - 182
  • [46] Metastases-directed SRT and systemic therapy: EORTC-ESTRO OligoCare delphi consensus recommendations
    Kroeze, S.
    Pavic, M.
    Stellamans, K.
    Lievens, Y.
    Becherini, C.
    Scorsetti, M.
    Alongi, F.
    Ricardi, U.
    Jereczek, B.
    Westhoff, P.
    But-Hadzic, J.
    Widder, J.
    Geets, X.
    Bral, S.
    Lambrecht, M.
    Billiet, C.
    Sirak, I.
    Ramella, S.
    Battista, I. G.
    Benavente, S.
    Zapatero, A.
    Romero, F.
    Zilli, T.
    Khanfir, K.
    Hemmatazad, H.
    De Bari, B.
    Klass, D.
    Adnan, S.
    Peulen, H.
    Ramos, J. Salinas
    Strijbos, M.
    Popat, S.
    Ost, P.
    Guckenberger, M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S205 - S207
  • [47] Report of outcomes of the first cohort of patients treated with SRS/SRT for brain metastases at a tertiary referral centre
    Malek, Abdul
    Harris, Fiona
    Burton, Katherine
    Jena, Rajesh
    Doherty, Gary
    Jefferies, Sarah
    CLINICAL ONCOLOGY, 2020, 32 : E2 - E2
  • [48] MELANOMA BRAIN METASTASES TREATED WITH SURGERY AND MULTIMODALITY THERAPY
    Duong, Huy T.
    Chaloner, Charlene
    Bordo, Gal
    Eisenberg, Amy
    Rosenthal, Katherine
    Sim, Myung-Shin
    Boasberg, Peter
    Faries, Mark B.
    Hamid, Omid
    Kelly, Daniel F.
    NEURO-ONCOLOGY, 2012, 14 : 88 - 88
  • [49] Effect of GTV Size on Dose Parameters Relevant to Radionecrosis in Linac-based Coplanar and Non-coplanar 5 Fraction SRT for Brain Metastases
    Maynard, Evan
    Lowe, Hunter
    Matthews, Quinn
    MEDICAL PHYSICS, 2024, 51 (08) : 5786 - 5787
  • [50] In-Field Maximum Point Dose Could be a Risk Factor of Radionecrosis in Patients With Brain Metastases Treated by Linear Accelerator-Based Stereotatic Radiosurgery
    Li, Q.
    Hu, J.
    Zhu, Y.
    Qiang, M.
    Deng, M.
    Cai, P.
    Xie, C.
    Qiu, B.
    Liu, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E89 - E89
12345